Functional selectivity in GPCR modulator screening

Combinatorial Chemistry and High Throughput Screening

Volumn 11, Issue 5, 2008, Pages 337-343

  Kenakin, Terry ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Allosteric modulators; Allosterism; High throughput screening

Indexed keywords

G PROTEIN COUPLED RECEPTOR;

AGONIST; ALLOSTERISM; BINDING AFFINITY; DRUG ACTIVITY; DRUG RESEARCH; DRUG SCREENING; DRUG SELECTIVITY; HIGH THROUGHPUT SCREENING; MOLECULAR MODEL; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW;

ALLOSTERIC REGULATION; ANIMALS; BINDING SITES; DRUG EVALUATION, PRECLINICAL; HUMANS; LIGANDS; RECEPTORS, G-PROTEIN-COUPLED; SENSITIVITY AND SPECIFICITY;

EID: 45149129202     PISSN: 13862073     EISSN: None     Source Type: Journal    
DOI: 10.2174/138620708784534824     Document Type: Review

References (19)

1. Ehlert, F. J. Mol. Pharmacol., 1988, 33, 187.
2. Black, J.W.; Leff, P. Proc. Roy. Soc. Lond. (Biol.), 1983, 220, 141.
3. Kenakin, T.P.; Jenkinson, S.; Watson, C. J. Pharmacol. Exp. Ther., 2006, 319, 710.
4. Bartus, R.T.; Dean, R.L.; Beer, B.; Lippa, A.S. Science, 1982, 217, 408.
5. Maelicke, A, ; Schrattenholz, A, ; Samochocki, M, ; Radina, M, ; Albuquerque, E.X. Behav. Brain Res., 2000, 11, 199.
6. Rogers, S.L.; Farlow, M.R.; Doody, R.S.; Mohs, R.; Friedhoff, L.T.; the Donepezil Study Group. Neurology, 1998, 50, 136.
7. Maelicke, A.; Albuquerque, E.X. Drug Discov. Today, 1996, 1, 59.
8. Krause R.M.; Buisson, B.; Bertrand, S.; Corringer, P.-J. ; Galzi, J.-L.; Changeux, J.-P.; Bertrand, D. Mol. Pharmacol., 1998, 53, 283.
9. Jakubic, J.; Bacakova, L.; Lisa, V.; El-Fakahany, E.E.; Tucek, S. Mol. Pharmacol., 1997, 52, 172.
10. Nagasaw, T.; Hirota, S.; Tachibana, K.; Takakura, N.; Nishikawa, S.; Kitamura, Y.; Yoshida, N.; Kikutani, H. ; Kishimoto, T. Nature, 1996, 382, 635.
11. Tachibana, K.; Hirota, S.; Iizasa, H.; Yoshida, H.; Kawabata, K.; Kataoka, Y,; Kitamura, Y.; Matsushima, K.; Yoshida, N.; Nishikawa, S.; Kishimoto, T. ; Nagasawa, T. Nature, 1998, 393, 591.
12. Zou, Y.R.; Kottmann, A.H.; Kuroda, M.; Taniuchi, I.; Littman, D.R. Nature, 1998, 393, 595.
13. Finke, P.E.; Oates, B,; Mills, S.G.; MacCoss, M.; Malkowitz, L.; Springer, M.S.; Gould, S.L.; DeMartino, J.A.; Carella, A.; Carver, G. Holmes K, Danzeisen R, Hazuda D, Kessler J, Lineberger J, Miller M, Schleif WA, Emini EA. Bioorg. Med. Chem. Lett., 2001, 11, 2475.
14. Maeda, K.; Nakata, H.; Koh, Y.; Miyakawa, T.; Ogata, H.; Takaoka, Y.; Sbibayama, S.; Sagawa, K.; Fukushima, D.; Moravek, J., Koyanagi, Y.; Mitsuya H. J. Virol., 2004, 78, 8654.
15. Watson, C.; Jenkinson, S.; Kazmierski, W.; Kenakin, T.P. Mol. Pharmacol., 2005, 67, 1268.
16. Cheng, Y.C.; Prusoff, W.H. Biochem. Pharmacol., 1973, 22, 3099.
17. Trankle, C.; Weyand, O.; Schroter, A.; Mohr, A. Mol. Pharmacol., 1999, 56, 962.
18. Kew, J.N.C.; Trube, G.; Kemp, J.A. J. Physiol., 1996, 497, 761.
19. Whitehurst, C.E.; Nazef, N.; Annis, D.A.; Hou, Y.; Murphy, D.M.; Spacciapoli, P.; Yao, Z.; Ziebell, M.R.; Cheng, C.C.; Shipps, G.W.; Felsch, J.S.; Lau, D.; Nash, H.W. J. Biomol. Screen., 2006, 11, 194.